Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jul 2;12(7):1943-6.
doi: 10.1080/21645515.2016.1151598. Epub 2016 May 10.

Response letter regarding the letter to the editors by Brown et al

Sylvia Taylor  1 , Martin Ryser  1 , Attila Mihalyi  1 , Thierry van Effelterre  1
Affiliations
Comment

Response letter regarding the letter to the editors by Brown et al

Sylvia Taylor et al. Hum Vaccin Immunother. .
No abstract available

Keywords: Cervarix™; HPV; cervical cancer; cross-protection; universal mass vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
HPV-007 /023 persistent vs. incident infection data (A) 6-month persistent infections; (B) Incident infections
See this image and copyright information in PMC

Comment on

References

    1. Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012. October; 12(10):781-9; PMID:22920953; http://dx.doi.org/10.1016/S1473-3099(12)70187-1 Epub 2012 Aug 22. - DOI - PubMed
    1. GSK Clinical Study Register. Study of the efficacy of candidate HPV 16/18 VLP vaccine in the prevention of HPV-16 and/or HPV-18 cervical infection in adolescent & young adult women in North America and Brazil vaccinated in primary study 580299/001. Available from: http://www.gsk-clinicalstudyregister.com/study/580299/007?study_ids=5802.... Updated 2011 Oct 27; accessed 2015 Sep 1. GSK Study ID 580299/007.
    1. GSK Clinical Study Register Follow-up study to evaluate the long-term efficacy of a HPV vaccine (580299) in healthy young adult women in Brazil. In: GSK Clinical Study Register [Internet]. Available from: http://www.gsk-clinicalstudyregister.com/study/109616%20%28Y7%29#rs. Updated 2014 Nov 20; accessed 2015 Sep 1. GSK Clinical Study Register Identifier: 109616 (Y7).
    1. Skinner SR, Apter D, De Carvalho N, Harper DM, Konno R, Paavonen J, Romanowski B, Roteli-Martins C, Burlet N, Mihalyi A and Struyf Frank. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases. Exp Rev Vacc 15(3):367-387. http://dx.doi.org/10.1586/14760584.2016.1124763. Epub 2016 Feb 22. - PubMed
    1. Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM et al.. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol 2015 Jul; 16(7):775-86; PMID:26071347; http://dx.doi.org/10.1016/S1470-2045(15)00047-9; Epub 2015 Jun 9 - DOI - PMC - PubMed

Substances

LinkOut - more resources